Cet anticorps Lapin Polyclonal détecte spécifiquement LEMD1 dans ELISA et WB. Il présente une réactivité envers Humain et Souris.
N° du produit ABIN6991612
Aperçu rapide pour LEMD1 anticorps (AA 90-140) (ABIN6991612)
Antigène
LEMD1
(LEM Domain Containing 1 (LEMD1))
Reactivité
Humain, Souris
Hôte
Lapin
Clonalité
Polyclonal
Conjugué
Cet anticorp LEMD1 est non-conjugé
Application
ELISA, Western Blotting (WB)
Épitope
AA 90-140
Specificité
At least six isoforms of LEMD1 are known to exist, this antibody will detect the longest isoform. LEMD1 antibody is predicted to not cross-react with LEMD2 and LEMD3.
Purification
LEMD1 Antibody is affinity chromatography purified via peptide column.
Immunogène
LEMD1 antibody was raised against a 19 amino acid synthetic peptide near the center of human LEMD1. The immunogen is located within amino acids 90 - 140 of LEMD1.
LEMD1
Reactivité: Humain, Souris
WB, EIA
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
LEMD1 antibody can be used for detection of LEMD1 by Western blot at 1 μ,g/mL.
Antibody validated: Western Blot in mouse samples. All other applications and species not yet tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
LEMD1 Antibody is supplied in PBS containing 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C,4 °C
Stockage commentaire
LEMD1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Antigène
LEMD1
(LEM Domain Containing 1 (LEMD1))
Autre désignation
LEMD1
Sujet
LEMD1 Antibody: LEMD1 (LEM domain-containing1) is a member of cancer-testis gene family. LEMD1 is normally expressed only in testis. Six alternatively spliced forms of LEMD1 transcripts in normal testis have been identified, but only one of the six was expressed in colorectal cancers. LEMD1 may represent a promising target antigen for immunotherapy of colorectal cancers. In addition, LEMD1 and SPATA19 are putative cancer biomarkers and promising targets for active immunotherapy.